{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "SNCA",
        "Protein_Change": {
          "ref": "G",
          "alt": "A",
          "position": "157"
        },
        "variant_string_id": "SNCA G157A"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "The c.157G>A base change (formerly reported as G209A) was detected in the patient's DNA and analyzed by PCR and restriction enzyme digestion.",
          "judgment": "Yes",
          "reasoning": "The paper identifies the SNCA gene mutation (c.157G>A) as associated with the disease, indicating the disease mechanism involves this gene."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "PCR and Tsp45I digestion were used to detect the c.157G>A variant in the patient's DNA.",
          "judgment": "Yes",
          "reasoning": "PCR followed by restriction enzyme digestion is a standard method for detecting base changes, applicable to assessing pathogenicity of SNCA variants.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3a: Basic Controls and Replicates",
          "extracted_paper_info": "PCR products and their Tsp45I digests were compared between patient (P) and normal (N) DNA samples.",
          "judgment": "Yes",
          "reasoning": "The experiment included both normal and patient DNA controls, indicating proper basic controls.",
          "next_step_or_outcome": "Proceed to Step 3c"
        },
        {
          "step_name": "Step 3c: Variant Controls",
          "extracted_paper_info": "Normal controls (N.2, N.3, N.4, N.5) and patient RNA were analyzed to assess SNCA mRNA levels.",
          "judgment": "Yes",
          "reasoning": "The use of multiple normal controls and patient RNA provides variant controls for assessing SNCA mRNA levels.",
          "next_step_or_outcome": "Proceed to Step 4"
        },
        {
          "step_name": "Step 4a: Statistical Analyses",
          "extracted_paper_info": "SNCA mRNA levels in controls were 65.1-86.2% of the patient level, quantified using Bio-gene V.97 software.",
          "judgment": "Yes",
          "reasoning": "The quantitation of mRNA levels using software indicates statistical analysis of the data.",
          "next_step_or_outcome": "Proceed to Step 4c"
        },
        {
          "step_name": "Step 4c: Correlate OddsPath",
          "extracted_paper_info": "SNCA mRNA levels in controls were 65.1-86.2% of the patient level.",
          "judgment": "Yes",
          "reasoning": "The significant difference in mRNA levels between patient and controls suggests a high OddsPath value, supporting pathogenicity.",
          "next_step_or_outcome": "Final strength rating determined"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_very_strong"
      },
      "overall_conclusion": "The variant c.157G>A in SNCA shows a significant increase in mRNA levels compared to controls, indicating a strong pathogenic effect."
    }
  ]
}